🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The company stated it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, positive reviews and detailed guides for preparing or administering at home.

After moments of entering one community, a vendor shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Details and Costs

Within these communities, posts show dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously seen patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject users to possibly significant health risks”.